ArticleCell journal2016

Upregulation of CD4+T-Cell Derived MiR-223 in The Relapsing Phase of Multiple Sclerosis Patients.

Aref Hosseini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.